nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—ABCB8—forebrain—attention deficit hyperactivity disorder	0.0175	0.0292	CbGeAlD
Doxorubicin—NDUFS7—forebrain—attention deficit hyperactivity disorder	0.0118	0.0197	CbGeAlD
Doxorubicin—AKR1A1—cardiovascular system—attention deficit hyperactivity disorder	0.011	0.0183	CbGeAlD
Doxorubicin—NDUFS7—cardiovascular system—attention deficit hyperactivity disorder	0.01	0.0167	CbGeAlD
Doxorubicin—NOS1—forebrain—attention deficit hyperactivity disorder	0.00986	0.0164	CbGeAlD
Doxorubicin—NDUFS2—forebrain—attention deficit hyperactivity disorder	0.0098	0.0163	CbGeAlD
Doxorubicin—NDUFS3—forebrain—attention deficit hyperactivity disorder	0.00968	0.0161	CbGeAlD
Doxorubicin—ABCB8—nervous system—attention deficit hyperactivity disorder	0.0095	0.0158	CbGeAlD
Doxorubicin—DHCR7—forebrain—attention deficit hyperactivity disorder	0.00919	0.0153	CbGeAlD
Doxorubicin—ABCB8—central nervous system—attention deficit hyperactivity disorder	0.00915	0.0152	CbGeAlD
Doxorubicin—CBR3—nervous system—attention deficit hyperactivity disorder	0.00915	0.0152	CbGeAlD
Doxorubicin—ABCB8—cerebellum—attention deficit hyperactivity disorder	0.00894	0.0149	CbGeAlD
Doxorubicin—CBR3—central nervous system—attention deficit hyperactivity disorder	0.00881	0.0147	CbGeAlD
Doxorubicin—CBR3—cerebellum—attention deficit hyperactivity disorder	0.00861	0.0143	CbGeAlD
Doxorubicin—AKR1A1—midbrain—attention deficit hyperactivity disorder	0.00859	0.0143	CbGeAlD
Doxorubicin—YWHAG—forebrain—attention deficit hyperactivity disorder	0.00844	0.0141	CbGeAlD
Doxorubicin—NOS1—cardiovascular system—attention deficit hyperactivity disorder	0.00834	0.0139	CbGeAlD
Doxorubicin—NDUFS2—cardiovascular system—attention deficit hyperactivity disorder	0.00828	0.0138	CbGeAlD
Doxorubicin—NDUFS3—cardiovascular system—attention deficit hyperactivity disorder	0.00818	0.0136	CbGeAlD
Doxorubicin—NDUFS7—midbrain—attention deficit hyperactivity disorder	0.00781	0.013	CbGeAlD
Doxorubicin—RALBP1—forebrain—attention deficit hyperactivity disorder	0.00762	0.0127	CbGeAlD
Doxorubicin—ABCC6—cardiovascular system—attention deficit hyperactivity disorder	0.00758	0.0126	CbGeAlD
Doxorubicin—NOS3—forebrain—attention deficit hyperactivity disorder	0.0075	0.0125	CbGeAlD
Doxorubicin—ABCB8—brain—attention deficit hyperactivity disorder	0.00726	0.0121	CbGeAlD
Doxorubicin—YWHAG—cardiovascular system—attention deficit hyperactivity disorder	0.00713	0.0119	CbGeAlD
Doxorubicin—CBR1—forebrain—attention deficit hyperactivity disorder	0.00711	0.0119	CbGeAlD
Doxorubicin—AKR1A1—nervous system—attention deficit hyperactivity disorder	0.00706	0.0118	CbGeAlD
Doxorubicin—CBR3—brain—attention deficit hyperactivity disorder	0.00699	0.0117	CbGeAlD
Doxorubicin—AKR1A1—central nervous system—attention deficit hyperactivity disorder	0.0068	0.0113	CbGeAlD
Doxorubicin—AKR1A1—cerebellum—attention deficit hyperactivity disorder	0.00665	0.0111	CbGeAlD
Doxorubicin—NDUFS2—midbrain—attention deficit hyperactivity disorder	0.00647	0.0108	CbGeAlD
Doxorubicin—RALBP1—cardiovascular system—attention deficit hyperactivity disorder	0.00644	0.0107	CbGeAlD
Doxorubicin—NDUFS7—nervous system—attention deficit hyperactivity disorder	0.00642	0.0107	CbGeAlD
Doxorubicin—NDUFS3—midbrain—attention deficit hyperactivity disorder	0.00639	0.0106	CbGeAlD
Doxorubicin—NOS3—cardiovascular system—attention deficit hyperactivity disorder	0.00634	0.0106	CbGeAlD
Doxorubicin—NDUFS7—central nervous system—attention deficit hyperactivity disorder	0.00618	0.0103	CbGeAlD
Doxorubicin—DHCR7—midbrain—attention deficit hyperactivity disorder	0.00607	0.0101	CbGeAlD
Doxorubicin—NDUFS7—cerebellum—attention deficit hyperactivity disorder	0.00604	0.0101	CbGeAlD
Doxorubicin—CBR1—cardiovascular system—attention deficit hyperactivity disorder	0.00601	0.01	CbGeAlD
Doxorubicin—AURKA—nervous system—attention deficit hyperactivity disorder	0.00597	0.00994	CbGeAlD
Doxorubicin—AURKA—central nervous system—attention deficit hyperactivity disorder	0.00574	0.00957	CbGeAlD
Doxorubicin—NQO1—forebrain—attention deficit hyperactivity disorder	0.0057	0.0095	CbGeAlD
Doxorubicin—YWHAG—midbrain—attention deficit hyperactivity disorder	0.00557	0.00928	CbGeAlD
Doxorubicin—AKR1A1—brain—attention deficit hyperactivity disorder	0.0054	0.00899	CbGeAlD
Doxorubicin—NOS1—nervous system—attention deficit hyperactivity disorder	0.00535	0.00892	CbGeAlD
Doxorubicin—NDUFS2—nervous system—attention deficit hyperactivity disorder	0.00532	0.00886	CbGeAlD
Doxorubicin—NDUFS3—nervous system—attention deficit hyperactivity disorder	0.00525	0.00875	CbGeAlD
Doxorubicin—NOS1—central nervous system—attention deficit hyperactivity disorder	0.00515	0.00859	CbGeAlD
Doxorubicin—NDUFS2—central nervous system—attention deficit hyperactivity disorder	0.00512	0.00853	CbGeAlD
Doxorubicin—NDUFS3—central nervous system—attention deficit hyperactivity disorder	0.00506	0.00843	CbGeAlD
Doxorubicin—NOS1—cerebellum—attention deficit hyperactivity disorder	0.00504	0.00839	CbGeAlD
Doxorubicin—RALBP1—midbrain—attention deficit hyperactivity disorder	0.00503	0.00838	CbGeAlD
Doxorubicin—NDUFS2—cerebellum—attention deficit hyperactivity disorder	0.005	0.00834	CbGeAlD
Doxorubicin—DHCR7—nervous system—attention deficit hyperactivity disorder	0.00499	0.00832	CbGeAlD
Doxorubicin—NDUFS3—cerebellum—attention deficit hyperactivity disorder	0.00494	0.00824	CbGeAlD
Doxorubicin—NDUFS7—brain—attention deficit hyperactivity disorder	0.00491	0.00818	CbGeAlD
Doxorubicin—NQO1—cardiovascular system—attention deficit hyperactivity disorder	0.00482	0.00803	CbGeAlD
Doxorubicin—DHCR7—central nervous system—attention deficit hyperactivity disorder	0.00481	0.00801	CbGeAlD
Doxorubicin—DHCR7—cerebellum—attention deficit hyperactivity disorder	0.0047	0.00783	CbGeAlD
Doxorubicin—CBR1—midbrain—attention deficit hyperactivity disorder	0.0047	0.00783	CbGeAlD
Doxorubicin—AKR1C3—midbrain—attention deficit hyperactivity disorder	0.00464	0.00773	CbGeAlD
Doxorubicin—YWHAG—nervous system—attention deficit hyperactivity disorder	0.00458	0.00763	CbGeAlD
Doxorubicin—AURKA—brain—attention deficit hyperactivity disorder	0.00456	0.0076	CbGeAlD
Doxorubicin—YWHAG—central nervous system—attention deficit hyperactivity disorder	0.00441	0.00735	CbGeAlD
Doxorubicin—YWHAG—cerebellum—attention deficit hyperactivity disorder	0.00431	0.00718	CbGeAlD
Doxorubicin—POR—midbrain—attention deficit hyperactivity disorder	0.00424	0.00706	CbGeAlD
Doxorubicin—RALBP1—nervous system—attention deficit hyperactivity disorder	0.00414	0.00689	CbGeAlD
Doxorubicin—NOS1—brain—attention deficit hyperactivity disorder	0.00409	0.00682	CbGeAlD
Doxorubicin—NOS3—nervous system—attention deficit hyperactivity disorder	0.00407	0.00678	CbGeAlD
Doxorubicin—NDUFS2—brain—attention deficit hyperactivity disorder	0.00407	0.00677	CbGeAlD
Doxorubicin—NDUFS3—brain—attention deficit hyperactivity disorder	0.00402	0.00669	CbGeAlD
Doxorubicin—RALBP1—central nervous system—attention deficit hyperactivity disorder	0.00398	0.00664	CbGeAlD
Doxorubicin—NOS3—central nervous system—attention deficit hyperactivity disorder	0.00392	0.00653	CbGeAlD
Doxorubicin—RALBP1—cerebellum—attention deficit hyperactivity disorder	0.00389	0.00649	CbGeAlD
Doxorubicin—CBR1—nervous system—attention deficit hyperactivity disorder	0.00386	0.00643	CbGeAlD
Doxorubicin—DHCR7—brain—attention deficit hyperactivity disorder	0.00382	0.00636	CbGeAlD
Doxorubicin—NQO1—midbrain—attention deficit hyperactivity disorder	0.00376	0.00627	CbGeAlD
Doxorubicin—CBR1—central nervous system—attention deficit hyperactivity disorder	0.00372	0.00619	CbGeAlD
Doxorubicin—CBR1—cerebellum—attention deficit hyperactivity disorder	0.00363	0.00605	CbGeAlD
Doxorubicin—AKR1C3—cerebellum—attention deficit hyperactivity disorder	0.00359	0.00598	CbGeAlD
Doxorubicin—YWHAG—brain—attention deficit hyperactivity disorder	0.0035	0.00583	CbGeAlD
Doxorubicin—CYP1B1—cardiovascular system—attention deficit hyperactivity disorder	0.00338	0.00564	CbGeAlD
Doxorubicin—ABCC10—midbrain—attention deficit hyperactivity disorder	0.00336	0.0056	CbGeAlD
Doxorubicin—POR—cerebellum—attention deficit hyperactivity disorder	0.00328	0.00546	CbGeAlD
Doxorubicin—RALBP1—brain—attention deficit hyperactivity disorder	0.00316	0.00527	CbGeAlD
Doxorubicin—NOS3—brain—attention deficit hyperactivity disorder	0.00311	0.00518	CbGeAlD
Doxorubicin—NQO1—nervous system—attention deficit hyperactivity disorder	0.00309	0.00516	CbGeAlD
Doxorubicin—NQO1—central nervous system—attention deficit hyperactivity disorder	0.00298	0.00496	CbGeAlD
Doxorubicin—CBR1—brain—attention deficit hyperactivity disorder	0.00295	0.00492	CbGeAlD
Doxorubicin—AKR1C3—brain—attention deficit hyperactivity disorder	0.00291	0.00486	CbGeAlD
Doxorubicin—NQO1—cerebellum—attention deficit hyperactivity disorder	0.00291	0.00485	CbGeAlD
Doxorubicin—ABCC3—nervous system—attention deficit hyperactivity disorder	0.00278	0.00463	CbGeAlD
Doxorubicin—ABCC3—central nervous system—attention deficit hyperactivity disorder	0.00267	0.00445	CbGeAlD
Doxorubicin—POR—brain—attention deficit hyperactivity disorder	0.00266	0.00444	CbGeAlD
Doxorubicin—ABCC10—cerebellum—attention deficit hyperactivity disorder	0.0026	0.00433	CbGeAlD
Doxorubicin—NQO1—brain—attention deficit hyperactivity disorder	0.00236	0.00394	CbGeAlD
Doxorubicin—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.00232	0.00387	CbGeAlD
Doxorubicin—CYP1B1—nervous system—attention deficit hyperactivity disorder	0.00217	0.00362	CbGeAlD
Doxorubicin—ABCC3—brain—attention deficit hyperactivity disorder	0.00212	0.00354	CbGeAlD
Doxorubicin—ABCC10—brain—attention deficit hyperactivity disorder	0.00211	0.00352	CbGeAlD
Doxorubicin—CYP1B1—central nervous system—attention deficit hyperactivity disorder	0.00209	0.00349	CbGeAlD
Doxorubicin—CYP1B1—cerebellum—attention deficit hyperactivity disorder	0.00204	0.00341	CbGeAlD
Doxorubicin—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00204	0.0034	CbGeAlD
Doxorubicin—ABCG2—midbrain—attention deficit hyperactivity disorder	0.00197	0.00328	CbGeAlD
Doxorubicin—ABCC1—cerebellum—attention deficit hyperactivity disorder	0.00184	0.00306	CbGeAlD
Doxorubicin—CYP1B1—brain—attention deficit hyperactivity disorder	0.00166	0.00277	CbGeAlD
Doxorubicin—ABCG2—cerebellum—attention deficit hyperactivity disorder	0.00152	0.00254	CbGeAlD
Doxorubicin—ABCC1—brain—attention deficit hyperactivity disorder	0.00149	0.00249	CbGeAlD
Doxorubicin—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.00149	0.00249	CbGeAlD
Doxorubicin—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00147	0.00245	CbGeAlD
Doxorubicin—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.00144	0.00239	CbGeAlD
Doxorubicin—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00124	0.00207	CbGeAlD
Doxorubicin—ABCG2—brain—attention deficit hyperactivity disorder	0.00124	0.00206	CbGeAlD
Doxorubicin—CYP2B6—brain—attention deficit hyperactivity disorder	0.00114	0.0019	CbGeAlD
Doxorubicin—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00113	0.00188	CbGeAlD
Doxorubicin—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00111	0.00185	CbGeAlD
Doxorubicin—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00109	0.00181	CbGeAlD
Doxorubicin—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00107	0.00178	CbGeAlD
Doxorubicin—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00104	0.00174	CbGeAlD
Doxorubicin—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00097	0.00162	CbGeAlD
Doxorubicin—CYP2D6—brain—attention deficit hyperactivity disorder	0.000848	0.00141	CbGeAlD
Doxorubicin—ABCB1—nervous system—attention deficit hyperactivity disorder	0.000798	0.00133	CbGeAlD
Doxorubicin—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.000768	0.00128	CbGeAlD
Doxorubicin—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.000751	0.00125	CbGeAlD
Doxorubicin—ABCB1—brain—attention deficit hyperactivity disorder	0.00061	0.00102	CbGeAlD
Doxorubicin—NDUFS2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000548	0.00137	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000543	0.00136	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000543	0.00136	CbGpPWpGaD
Doxorubicin—CYP1B1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00054	0.00135	CbGpPWpGaD
Doxorubicin—CYP1B1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000536	0.00134	CbGpPWpGaD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000534	0.00134	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000534	0.00134	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000533	0.00133	CbGpPWpGaD
Doxorubicin—CYP1B1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000532	0.00133	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000521	0.0013	CbGpPWpGaD
Doxorubicin—NOS3—Disease—STUB1—attention deficit hyperactivity disorder	0.00052	0.0013	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000497	0.00124	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000485	0.00121	CbGpPWpGaD
Doxorubicin—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000468	0.00117	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000467	0.00117	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000466	0.00116	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000459	0.00115	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000454	0.00114	CbGpPWpGaD
Doxorubicin—ABCG2—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000453	0.00113	CbGpPWpGaD
Doxorubicin—NOS2—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000446	0.00112	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000443	0.00111	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000443	0.00111	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—COMT—attention deficit hyperactivity disorder	0.000441	0.0011	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000441	0.0011	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000438	0.0011	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000438	0.0011	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000434	0.00109	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000431	0.00108	CbGpPWpGaD
Doxorubicin—NOS1—Disease—SNAP25—attention deficit hyperactivity disorder	0.000421	0.00105	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000415	0.00104	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000413	0.00103	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000412	0.00103	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000412	0.00103	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000397	0.000993	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000374	0.000936	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000371	0.000927	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000369	0.000923	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000364	0.000911	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000363	0.000908	CbGpPWpGaD
Doxorubicin—CYP2B6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00036	0.0009	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000357	0.000894	CbGpPWpGaD
Doxorubicin—CYP2B6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000357	0.000894	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000356	0.00089	CbGpPWpGaD
Doxorubicin—CYP2B6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000355	0.000888	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—COMT—attention deficit hyperactivity disorder	0.000353	0.000882	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000351	0.000878	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00035	0.000876	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000347	0.000868	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.00034	0.00085	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000329	0.000823	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000328	0.000819	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000327	0.000817	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000323	0.000808	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000318	0.000795	CbGpPWpGaD
Doxorubicin—NOS2—Disease—SNAP25—attention deficit hyperactivity disorder	0.000318	0.000795	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—STUB1—attention deficit hyperactivity disorder	0.000317	0.000793	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000317	0.000793	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000317	0.000793	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000317	0.000792	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000313	0.000783	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000313	0.000781	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000312	0.00078	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000307	0.000767	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000306	0.000765	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000306	0.000765	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000306	0.000765	CbGpPWpGaD
Doxorubicin—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000306	0.000764	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000305	0.000763	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000304	0.00076	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000301	0.000753	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000301	0.000752	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—SNAP25—attention deficit hyperactivity disorder	0.000292	0.00073	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000291	0.000728	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.00029	0.000726	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00029	0.000725	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000284	0.000711	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000284	0.000711	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000283	0.000707	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00028	0.0007	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00028	0.0007	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00026	0.00065	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.00026	0.000649	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000258	0.000646	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000258	0.000646	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000254	0.000636	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000253	0.000634	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000252	0.000629	CbGpPWpGaD
Doxorubicin—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00025	0.000626	CbGpPWpGaD
Doxorubicin—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000248	0.000621	CbGpPWpGaD
Doxorubicin—NOS3—Disease—SNAP25—attention deficit hyperactivity disorder	0.000247	0.000617	CbGpPWpGaD
Doxorubicin—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000247	0.000617	CbGpPWpGaD
Doxorubicin—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000245	0.000613	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000245	0.000612	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000242	0.000606	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000241	0.000603	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00024	0.000599	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000236	0.000591	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000234	0.000585	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000233	0.000582	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000228	0.000571	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000227	0.000569	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000226	0.000566	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000221	0.000552	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.00022	0.00055	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00022	0.00055	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000216	0.000541	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000213	0.000533	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000213	0.000532	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000211	0.000527	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00021	0.000524	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00021	0.000524	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000207	0.000517	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000206	0.000516	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000204	0.000511	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000201	0.000503	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000201	0.000503	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000201	0.000502	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000198	0.000495	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000198	0.000495	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.000197	0.000492	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000197	0.000492	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000195	0.000487	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000192	0.000481	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000192	0.00048	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000192	0.00048	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000191	0.000477	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—EP300—attention deficit hyperactivity disorder	0.000189	0.000473	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—EP300—attention deficit hyperactivity disorder	0.000189	0.000473	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000186	0.000465	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000185	0.000463	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000184	0.00046	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000184	0.00046	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000179	0.000448	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000178	0.000446	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000178	0.000445	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000173	0.000432	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—COMT—attention deficit hyperactivity disorder	0.000172	0.000431	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000171	0.000428	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000168	0.000419	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000167	0.000418	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000166	0.000414	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000164	0.000411	CbGpPWpGaD
Doxorubicin—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000164	0.000409	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000162	0.000406	CbGpPWpGaD
Doxorubicin—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000162	0.000406	CbGpPWpGaD
Doxorubicin—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000161	0.000403	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000161	0.000402	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00016	0.000399	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000158	0.000394	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000158	0.000394	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000157	0.000392	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000155	0.000389	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000155	0.000387	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.000154	0.000385	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000153	0.000383	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000152	0.000381	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000152	0.000381	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000151	0.000378	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—EP300—attention deficit hyperactivity disorder	0.000151	0.000378	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—SNAP25—attention deficit hyperactivity disorder	0.00015	0.000376	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00015	0.000375	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000147	0.000368	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000144	0.00036	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000141	0.000353	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000139	0.000348	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000139	0.000347	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000139	0.000347	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.000138	0.000344	CbGpPWpGaD
Doxorubicin—NOS1—Disease—EP300—attention deficit hyperactivity disorder	0.000137	0.000342	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000136	0.000341	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—COMT—attention deficit hyperactivity disorder	0.000127	0.000318	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000127	0.000317	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000126	0.000315	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000126	0.000315	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000125	0.000314	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000122	0.000306	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000122	0.000305	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000122	0.000305	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000121	0.000302	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.00012	0.0003	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00012	0.0003	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000117	0.000293	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000116	0.00029	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000114	0.000285	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000111	0.000277	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000109	0.000271	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000106	0.000265	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000105	0.000264	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000105	0.000262	CbGpPWpGaD
Doxorubicin—NOS2—Disease—EP300—attention deficit hyperactivity disorder	0.000103	0.000258	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000102	0.000256	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000102	0.000254	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000102	0.000254	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	9.99e-05	0.00025	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—COMT—attention deficit hyperactivity disorder	9.54e-05	0.000239	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—EP300—attention deficit hyperactivity disorder	9.49e-05	0.000237	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—MAOA—attention deficit hyperactivity disorder	9.48e-05	0.000237	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.29e-05	0.000232	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—COMT—attention deficit hyperactivity disorder	9.23e-05	0.000231	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	9.19e-05	0.00023	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—MAOA—attention deficit hyperactivity disorder	9.16e-05	0.000229	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	8.89e-05	0.000222	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—COMT—attention deficit hyperactivity disorder	8.4e-05	0.00021	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—MAOA—attention deficit hyperactivity disorder	8.34e-05	0.000208	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—EP300—attention deficit hyperactivity disorder	8.24e-05	0.000206	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.12e-05	0.000203	CbGpPWpGaD
Doxorubicin—NOS3—Disease—EP300—attention deficit hyperactivity disorder	8.02e-05	0.000201	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—EP300—attention deficit hyperactivity disorder	7.95e-05	0.000199	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.73e-05	0.000193	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.49e-05	0.000187	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	7.49e-05	0.000187	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—EP300—attention deficit hyperactivity disorder	7.39e-05	0.000185	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	7.37e-05	0.000184	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	7.06e-05	0.000177	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.06e-05	0.000177	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	6.95e-05	0.000174	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.85e-05	0.000171	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—EP300—attention deficit hyperactivity disorder	6.72e-05	0.000168	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	6.69e-05	0.000167	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.65e-05	0.000166	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.46e-05	0.000161	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	6.16e-05	0.000154	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	6.11e-05	0.000153	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.99e-05	0.00015	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.7e-05	0.000143	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.64e-05	0.000141	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.62e-05	0.00014	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—EP300—attention deficit hyperactivity disorder	5.45e-05	0.000136	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.37e-05	0.000134	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—EP300—attention deficit hyperactivity disorder	5.22e-05	0.000131	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—EP300—attention deficit hyperactivity disorder	4.89e-05	0.000122	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	4.62e-05	0.000115	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.62e-05	0.000115	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	4.54e-05	0.000114	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	4.54e-05	0.000114	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	4.51e-05	0.000113	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	4.28e-05	0.000107	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	4.25e-05	0.000106	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.22e-05	0.000106	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—EP300—attention deficit hyperactivity disorder	4.09e-05	0.000102	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—EP300—attention deficit hyperactivity disorder	3.96e-05	9.9e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.69e-05	9.23e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—EP300—attention deficit hyperactivity disorder	3.6e-05	9e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.51e-05	8.79e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	2.8e-05	6.99e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	2.78e-05	6.94e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	2.64e-05	6.6e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	1.95e-05	4.87e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	1.83e-05	4.59e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.2e-05	3e-05	CbGpPWpGaD
